Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
Date:11/9/2010

266)$(34,835)$(96,293)$(123,432)Net loss per share, basic & diluted

$(0.31)$(0.38)$(0.91)$(1.51)Shares used in calculating net loss per share, basic & diluted

117,40990,995105,58281,518Arena Pharmaceuticals, Inc.Condensed Consolidated Balance Sheet Data(In thousands)September 30, 2010December 31, 2009(unaudited)*Assets  Cash, cash equivalents & short-term investments

$ 176,536$ 115,449  Accounts receivable

1,9721,415  Other current assets

3,2744,409  Land, property & equipment, net

93,08195,445  Acquired technology & other non-current assets

18,17719,560Total assets

$ 293,040$ 236,278Liabilities and Stockholders' Equity  Accounts payable and accrued liabilities

$   13,762$   15,884  Total deferred revenues

49,0464,086  Total derivative liabilities

1,7856,642  Total note payable to Siegfried

9,8889,143  Total note payable to Deerfield**35,43447,906  Total lease financing obligations & other long-term liabilities

77,41978,050  Total stockholders' equity

105,70674,567Total liabilities & stockholders' equity

$ 293,040$ 236,278* The condensed consolidated balance sheet data as of December 31, 2009, has been derived from the audited financial statements as of that date.

** The outstanding principal balance of the note payable to Deerfield was $60.0 million and $90.0 million at September 30, 2010 and December 31, 2009, respectively.


'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
2. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
3. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
4. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
5. Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
6. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
7. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
8. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
9. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
10. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
11. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Sept. 17, 2014 Research and Markets ... Breast Cancer Market 2014-2018" report to their offering. ... uncontrolled growth of cancerous cells in the breast tissue. ... breast cancer is rare. Histologically, breast cancer can be ... other undifferentiated carcinoma. Ductal carcinoma is the form of ...
(Date:9/17/2014)... Switzerland , September 17, 2014 ... is proud to congratulate Biocartis commitment in shipping ... is a long-time investor in Biocartis as part ... Biocartis, fully automated, real-time PCR based molecular ... and easy access to clinical molecular diagnostic information, ...
(Date:9/16/2014)... Massachusetts , 17. September 2014 ... HOLX ), hat heute die ... zur präanalytischen Probenverarbeitung, in Europa bekannt ... gekennzeichnete, vollautomatisierte Universalplattform zur Vereinfachung der ... dass ineffiziente und fehlerbehaftete Arbeitsschritte bei ...
Breaking Medicine Technology:Global Breast Cancer Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Company and F. Hoffmann-La Roche, Novartis and Sanofi-Aventis 2Global Breast Cancer Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Company and F. Hoffmann-La Roche, Novartis and Sanofi-Aventis 3Debiopharm Diagnostics Portfolio Company Biocartis Ships its First Idylla Instrument 2Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 2Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 3
... KARLSRUHE, Germany, March 4, 2011 The High Court of ... favor of AmniSure® International, LLC in its dispute with the ... Court,s ruling that the patent associated with Medix,s ActimPROM test ... inventive step. Medix is expected to pay AmniSure® an undisclosed ...
... -- Bacterin International Holdings, Inc. (OTC Bulletin Board: ... revolutionary bone graft material and anti-infective coatings for medical applications, ... listing on the NYSE Amex and has chosen Knight Capital ... stock will commence trading on the NYSE Amex on Monday, ...
Cached Medicine Technology:German High Court Rules in Favor of AmniSure® as New European Guidelines Published 2Bacterin International Holdings, Inc. Receives Approval for Listing on NYSE Amex 2Bacterin International Holdings, Inc. Receives Approval for Listing on NYSE Amex 3
(Date:9/17/2014)... 2014 There’s something changing the ... of all ages an all-natural option for PMS ... women, for women, announces the launch of its ... to relieve the symptoms commonly associated with monthly ... , As a lifelong health enthusiast and busy ...
(Date:9/17/2014)... A raucous childhood in an Italian-Polish family and ... Nancy Chovancek’s laughter-filled new book, “Angry Birds and Beehive ... stories that prove the best way to deal with ... of empowerment and resilience, everyone can identify with Chovancek’s ... two books under her belt on the topic of ...
(Date:9/17/2014)... Diabetes currently has no cure. According to ... scientists made several breakthroughs in search for ... article indicates that cure for diabetes is still many ... many forward-thinking entrepreneurs and health professionals who made strides ... Dr. Kenneth Pullman is one of the individuals with ...
(Date:9/17/2014)... AURORA, Colo. (PRWEB) September 17, 2014 ... American Sentinel University offers tips to health IT professionals ... , A recent study by HIMSS shows demand ... high and a candidate’s skill set is the differentiating ... is that of an IT professional that has clinical ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 On October ... wellness to the lineup at Techmanity, a celebration of ... next generation of tech events,” Techmanity will host the ... excited to join the ranks of Cisco, PayPal, Samsung, ... ever Silicon Valley Technology Conference. , Voom was created ...
Breaking Medicine News(10 mins):Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 2Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 3Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 4Health News:Discover a Safe and Effective Treatment for Diabetes with The Diabetes Protocol – Vinamy 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4Health News:Health and Wellness Startup Voom Announces Sponsorship at Techmanity 2
... past have argued about the implications of Hormone Replacement Therapy ... A new study, however, has gone further to show that ... developing breast cancer// if they consumed alcoholic beverages. ,The ... pattern and on whether they were on HRT currently or ...
... have found that people who take anti-depressants to relieve ... developing gastrointestinal bleeding. The study which was conducted over ... were compared for hospitalizations due to upper GI bleeding ... on selective serotonin reuptake inhibitors, or SSRIs, were 3.6-times ...
... by a Diabetes Research Centre in India has shown that ... had considerable improvement when they followed safe practices advised by ... doctors discovering that many patients came to the Centre with ... their lives. They decided that a little change in lifestyle ...
... called 'HERS' conducted by researchers of the University of California, ... that Hormone Replacement Therapy (HRT) may be able to reduce ... develop diabetes as well. ,The study involved some women ... had "impaired fasting glucose" - a condition with some ...
... 61 previous studies of blood pressure and cardiovascular disease, which ... regardless of age and even if readings are in the ... reducing risk of strokes and heart attacks. ,The study ... that out of the 120,000 who died, 56,000 suffered fatal ...
... Chairman and Managing Director of Eli Lilly and Co., India, ... cut in the company's human insulin product 'Huminsulin', that its ... market by the end of this year. He added that ... use of human insulin products and the phasing out of ...
Cached Medicine News:Health News:Women on HRT should avoid alcohol 2
Cholesterol FS. For determination of cholesterol in serum or plasma. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P Trulab L....
Intended for the quantitative determination of total cholesterol in serum. Single vial, dry powder reagent. Reaction: Endpoint. Wavelength: 500 nm. Linearity: 700 mg/dL (12.9 mmol/L)....
This true 8-bit integrated and cooled imaging system is a completely self contained unit built with a long list of standard features including all-electronic-variable transilluminator and EPI lightin...
... range of Platelet aggregometers allows to ... particular needs. Single, dual and four ... recorder outputs or digital computer outputs. ... aggregometers, which measure platelet aggregation in ...
Medicine Products: